Company profile MYGN
After 38 days of this quarter the interest is at 300.0. Based on that we can calculate that during remaining 53 days it will total up to 718.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 280 | 631 125.4% QoQ | 758 20.1% QoQ | 616 -18.7% QoQ |
| 2020 | 692 147.1% YoY 12.3% QoQ | 483 -23.5% YoY -30.2% QoQ | 517 -31.8% YoY 7.0% QoQ | 464 -24.7% YoY -10.3% QoQ |
| 2021 | 497 -28.2% YoY 7.1% QoQ | 531 9.9% YoY 6.8% QoQ | 722 39.7% YoY 36.0% QoQ | 583 25.6% YoY -19.3% QoQ |
| 2022 | 704 41.6% YoY 20.8% QoQ | 824 55.2% YoY 17.0% QoQ | 855 18.4% YoY 3.8% QoQ | 825 41.5% YoY -3.5% QoQ |
| 2023 | 891 26.6% YoY 8.0% QoQ | 998 21.1% YoY 12.0% QoQ | 988 15.6% YoY -1.0% QoQ | 767 -7.0% YoY -22.4% QoQ |
| 2024 | 300 -66.3% YoY -60.9% QoQ | - | - | - |
The average 5 years interest of Myriad Genetics was 53.56 per week. The last year interest of Myriad Genetics compared to the last 5 years has changed by 28.32%. The interest for Myriad Genetics is trending. The last year interest is quite higher compared to 5 years ago. It has increased by 36.94%.
After 38 days of this quarter the interest is at 25.0. Based on that we can calculate that during remaining 53 days it will total up to 60.0. Myriad Genetics testing expected interest is significantly lower compared to same quarter last year (-66.3%) but similar to previous quarter.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 75 | 49 -34.7% QoQ | 26 -46.9% QoQ | 186 615.4% QoQ |
| 2020 | 76 1.3% YoY -59.1% QoQ | 92 87.8% YoY 21.1% QoQ | 122 369.2% YoY 32.6% QoQ | 58 -68.8% YoY -52.5% QoQ |
| 2021 | 151 98.7% YoY 160.3% QoQ | 259 181.5% YoY 71.5% QoQ | 71 -41.8% YoY -72.6% QoQ | 178 206.9% YoY 150.7% QoQ |
| 2022 | 76 -49.7% YoY -57.3% QoQ | 164 -36.7% YoY 115.8% QoQ | 236 232.4% YoY 43.9% QoQ | 195 9.6% YoY -17.4% QoQ |
| 2023 | 178 134.2% YoY -8.7% QoQ | 92 -43.9% YoY -48.3% QoQ | 96 -59.3% YoY 4.3% QoQ | 94 -51.8% YoY -2.1% QoQ |
| 2024 | 25 -86.0% YoY -73.4% QoQ | - | - | - |
The average 5 years interest of Myriad Genetics testing was 9.61 per week. The last year interest of Myriad Genetics testing compared to the last 5 years has changed by -9.78%. This is something to be checked. The last year interest is comparable to 5 years ago. It has changed only by 14.99%.
After 39 days of this quarter the interest is at 445.0. Based on that we can calculate that during remaining 52 days it will total up to 1038.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 554 | 828 49.5% QoQ | 780 -5.8% QoQ | 814 4.4% QoQ |
| 2020 | 784 41.5% YoY -3.7% QoQ | 665 -19.7% YoY -15.2% QoQ | 730 -6.4% YoY 9.8% QoQ | 756 -7.1% YoY 3.6% QoQ |
| 2021 | 813 3.7% YoY 7.5% QoQ | 808 21.5% YoY -0.6% QoQ | 794 8.8% YoY -1.7% QoQ | 788 4.2% YoY -0.8% QoQ |
| 2022 | 978 20.3% YoY 24.1% QoQ | 914 13.1% YoY -6.5% QoQ | 813 2.4% YoY -11.1% QoQ | 905 14.8% YoY 11.3% QoQ |
| 2023 | 1040 6.3% YoY 14.9% QoQ | 966 5.7% YoY -7.1% QoQ | 937 15.3% YoY -3.0% QoQ | 1134 25.3% YoY 21.0% QoQ |
| 2024 | 445 -57.2% YoY -60.8% QoQ | - | - | - |
The average 5 years interest of genetic testing was 66.08 per week. The last year interest of genetic testing compared to the last 5 years has changed by 17.92%. The interest for genetic testing is relatively stable and increasing in the last 5 years. The last year interest is quite higher compared to 5 years ago. It has increased by 21.98%.
After 38 days of this quarter the interest is at 328.0. Based on that we can calculate that during remaining 53 days it will total up to 785.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 581 | 771 32.7% QoQ | 829 7.5% QoQ | 660 -20.4% QoQ |
| 2020 | 732 26.0% YoY 10.9% QoQ | 680 -11.8% YoY -7.1% QoQ | 658 -20.6% YoY -3.2% QoQ | 595 -9.8% YoY -9.6% QoQ |
| 2021 | 684 -6.6% YoY 15.0% QoQ | 672 -1.2% YoY -1.8% QoQ | 691 5.0% YoY 2.8% QoQ | 720 21.0% YoY 4.2% QoQ |
| 2022 | 931 36.1% YoY 29.3% QoQ | 969 44.2% YoY 4.1% QoQ | 910 31.7% YoY -6.1% QoQ | 815 13.2% YoY -10.4% QoQ |
| 2023 | 1051 12.9% YoY 29.0% QoQ | 1009 4.1% YoY -4.0% QoQ | 970 6.6% YoY -3.9% QoQ | 892 9.4% YoY -8.0% QoQ |
| 2024 | 328 -68.8% YoY -63.2% QoQ | - | - | - |
The average 5 years interest of precision medicine was 62.11 per week. The last year interest of precision medicine compared to the last 5 years has changed by 18.53%. The interest for precision medicine is relatively stable and increasing in the last 5 years. The last year interest is quite higher compared to 5 years ago. It has increased by 22.27%.
After 38 days of this quarter the interest is at 82.0. Based on that we can calculate that during remaining 53 days it will total up to 196.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 37 | 222 500.0% QoQ | 249 12.2% QoQ | 83 -66.7% QoQ |
| 2020 | 139 275.7% YoY 67.5% QoQ | 104 -53.2% YoY -25.2% QoQ | 40 -83.9% YoY -61.5% QoQ | 33 -60.2% YoY -17.5% QoQ |
| 2021 | 86 -38.1% YoY 160.6% QoQ | 54 -48.1% YoY -37.2% QoQ | 172 330.0% YoY 218.5% QoQ | 25 -24.2% YoY -85.5% QoQ |
| 2022 | 29 -66.3% YoY 16.0% QoQ | 171 216.7% YoY 489.7% QoQ | 122 -29.1% YoY -28.7% QoQ | 51 104.0% YoY -58.2% QoQ |
| 2023 | 243 737.9% YoY 376.5% QoQ | 142 -17.0% YoY -41.6% QoQ | 113 -7.4% YoY -20.4% QoQ | 162 217.6% YoY 43.4% QoQ |
| 2024 | 82 -66.3% YoY -49.4% QoQ | - | - | - |
The average 5 years interest of MyRisk Hereditary Cancer Test was 9.07 per week. The last year interest of MyRisk Hereditary Cancer Test compared to the last 5 years has changed by 40.57%. This is something to be checked. The last year interest is comparable to 5 years ago. It has changed only by -1.16%.
There is not enough data for BRACAnalysis CDx Germline Companion Diagnostic Test to provide analysis
There is not enough data for BRACAnalysis CDx Germline Companion Diagnostic Test to provide correlation calculation
There is not enough data for BRACAnalysis CDx Germline Companion Diagnostic Test to provide analysis
There is not enough data for MyChoice CDx Companion Diagnostic Test to provide analysis
There is not enough data for MyChoice CDx Companion Diagnostic Test to provide correlation calculation
There is not enough data for MyChoice CDx Companion Diagnostic Test to provide analysis
There is not enough data for Prolaris Prostate Cancer Prognostic Test to provide analysis
There is not enough data for Prolaris Prostate Cancer Prognostic Test to provide correlation calculation
There is not enough data for Prolaris Prostate Cancer Prognostic Test to provide analysis
There is not enough data for EndoPredict Breast Cancer Prognostic Test to provide analysis
There is not enough data for EndoPredict Breast Cancer Prognostic Test to provide correlation calculation
There is not enough data for EndoPredict Breast Cancer Prognostic Test to provide analysis
There is not enough data for Precise Tumor to provide analysis
There is not enough data for Precise Tumor to provide correlation calculation
There is not enough data for Precise Tumor to provide analysis
After 38 days of this quarter the interest is at 44.0. Based on that we can calculate that during remaining 53 days it will total up to 105.0. Prequel Prenatal Screen expected interest is significantly lower compared to same quarter last year (-50.9%) but similar to previous quarter.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 127 | 159 25.2% QoQ | 245 54.1% QoQ | 145 -40.8% QoQ |
| 2020 | 230 81.1% YoY 58.6% QoQ | 233 46.5% YoY 1.3% QoQ | 223 -9.0% YoY -4.3% QoQ | 102 -29.7% YoY -54.3% QoQ |
| 2021 | 386 67.8% YoY 278.4% QoQ | 219 -6.0% YoY -43.3% QoQ | 120 -46.2% YoY -45.2% QoQ | 173 69.6% YoY 44.2% QoQ |
| 2022 | 148 -61.7% YoY -14.5% QoQ | 282 28.8% YoY 90.5% QoQ | 192 60.0% YoY -31.9% QoQ | 112 -35.3% YoY -41.7% QoQ |
| 2023 | 214 44.6% YoY 91.1% QoQ | 125 -55.7% YoY -41.6% QoQ | 188 -2.1% YoY 50.4% QoQ | 82 -26.8% YoY -56.4% QoQ |
| 2024 | 44 -79.4% YoY -46.3% QoQ | - | - | - |
The average 5 years interest of Prequel Prenatal Screen was 14.42 per week. The last year interest of Prequel Prenatal Screen compared to the last 5 years has changed by -18.52%. This is something to be checked. The last year interest is quite lower compared to 5 years ago. It has decreased by -25.21%.
After 38 days of this quarter the interest is at 52.0. Based on that we can calculate that during remaining 53 days it will total up to 125.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 74 | 200 170.3% QoQ | 144 -28.0% QoQ | 209 45.1% QoQ |
| 2020 | 215 190.5% YoY 2.9% QoQ | 172 -14.0% YoY -20.0% QoQ | 401 178.5% YoY 133.1% QoQ | 280 34.0% YoY -30.2% QoQ |
| 2021 | 226 5.1% YoY -19.3% QoQ | 204 18.6% YoY -9.7% QoQ | 174 -56.6% YoY -14.7% QoQ | 28 -90.0% YoY -83.9% QoQ |
| 2022 | 222 -1.8% YoY 692.9% QoQ | 187 -8.3% YoY -15.8% QoQ | 90 -48.3% YoY -51.9% QoQ | 121 332.1% YoY 34.4% QoQ |
| 2023 | 135 -39.2% YoY 11.6% QoQ | 225 20.3% YoY 66.7% QoQ | 147 63.3% YoY -34.7% QoQ | 101 -16.5% YoY -31.3% QoQ |
| 2024 | 52 -61.5% YoY -48.5% QoQ | - | - | - |
The average 5 years interest of Foresight Carrier Screen was 13.87 per week. The last year interest of Foresight Carrier Screen compared to the last 5 years has changed by -13.48%. This is something to be checked. The last year interest is quite lower compared to 5 years ago. It has decreased by -22.48%.
There is not enough data for GeneSight Psychotropic Mental Health Medication Test to provide analysis
There is not enough data for GeneSight Psychotropic Mental Health Medication Test to provide correlation calculation
There is not enough data for GeneSight Psychotropic Mental Health Medication Test to provide analysis
There is not enough data for Illumina collaboration to provide analysis
There is not enough data for Illumina collaboration to provide correlation calculation
There is not enough data for Illumina collaboration to provide analysis
There is not enough data for Intermountain Precision Genomics to provide analysis
There is not enough data for Intermountain Precision Genomics to provide correlation calculation
There is not enough data for Intermountain Precision Genomics to provide analysis